AB LITTLEJOHN & SONS LIMITEDActive

Company number SC436915Private limited companyIncorporated 2012

Key figures

£661,576+9.7%
Net assets 2025
+32.6%
Average annual growth 2020–2025
0200 k400 k600 k800 k202020212022202320242025

Like most small UK companies, AB LITTLEJOHN & SONS LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2025
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
01 m2 m202020212022202320242025
Filed accounts2020–2025
20212022202320242025
Cash at bank and in hand61,36667,02485,740186,78574,107
Total assets1,639,8601,760,6941,518,6781,614,7471,504,108
Total liabilities1,266,1121,101,571988,689964,584766,776
Net assets / total equity373,748643,846511,393603,050661,576
Average number of employees353435390

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: AB LITTLEJOHN & SONS LIMITED

Company

AB LITTLEJOHN & SONS LIMITED is a private limited company registered with Companies House under company number SC436915. It was incorporated on 15 Nov 2012. Its status is active. The registered office is in Glasgow (G31). Its nature of business (SIC 2007) is manufacture of medical and dental instruments and supplies (32500).

Accounts

The latest accounts in the database are for 2025 (period ending 31 Dec 2025); the company files small company accounts (filleted). Net assets were £661,576, up 9.7% on the previous year. Cash at bank and in hand was £74,107. Total assets were £1,504,108 and total liabilities £766,776. The company had an average of 0 employees. Figures are available for 6 financial years (2020–2025).

Control and charges

3 persons with significant control are registered. 2 of 5 registered charges are outstanding.

Filing deadlines

The next accounts are due by 30 Sep 2027. The next confirmation statement is due by 29 Nov 2026.